CoChat

Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis

Open access

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Background: Outcome reporting bias (ORB) in randomised trials has been identified as a threat to the validity of systematic reviews. Previous work highlighting this problem is limited to considering a single primary review outcome. The aim of this study was to assess ORB across all efficacy outcomes in the Cochrane systematic reviews of cystic fibrosis. Methods: Systematic reviews of interventions for cystic fibrosis published on the Cochrane Library by the Cochrane Cystic Fibrosis and Genetic Disorders Group before 2010 were assessed for discrepancies in outcomes between review protocol and full review. ORB in eligible trials was also assessed for all efficacy review outcomes. Two authors independently classified each outcome using a nine-point classification system developed by the Outcome Reporting Bias In Trials study. These classifications were used to inform the assessment of the risk of bias for selective outcome reporting for each trial. Results: –46 Cochrane cystic fibrosis systematic reviews were included. The median number of primary outcomes, number of trials and participants per trial in the reviews were 3 (IQR 2, 3), 4 (IQR 2, 8) and 21 (IQR 14, 41), respectively. 18 reviews (39%, 18/46) had a discrepancy in outcomes between protocol and full review. 37 reviews were eligible to be included in the ORB assessment. When considering review primary outcomes and all review outcomes, ORB was suspected in at least one trial in 86% and 100%, respectively. Conclusions: Assessment of ORB within a systematic review of a single primary outcome underestimates the risk of ORB in comparison to the assessment of multiple primary and secondary outcomes. ORB in trials is highly prevalent within systematic reviews of cystic fibrosis when assessed across all outcomes. This could be reduced by the development of a core outcome set for trials and systematic reviews in cystic fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2013-002709

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study flow diagram.
Figure 1 Study flow diagram.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 2

  1. Von Mosch S Dwan K Reporting of harm and efficacy outcomes of randomised clinical trials in cystic fibrosis before and after the publication of the revised CONSORT (CONsolidated Standards Of Reporting Trials) statement in 2001—a comparison of trial reports published from 1994 and from 2008 [ thesis]. The University of Liverpool, 2011
  2. The Cochrane Library, Issue 4, Chichester: Wiley, 2009

Cited by

See all 55

Metadata

Authors
Dwan, K., Kirkham, J. J., Williamson, P. R., & Gamble, C.
Affiliations
University of Liverpool (GB)
Corresponding author
Dwan, Kerry
Venue
BMJ Open
Publisher
BMJ
Published
2013-05
Volume
3
Issue
6
Pages
e002709
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2084159208
Cited by
55
References
20
Citations by year
2026: 1 · 2025: 2 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 16 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 3
FWCI
0.89
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • National Institute for Health and Care Research
  • Medical Research Council
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
selective reporting, selective outcome reporting, cystic fibrosis, systematic reviews, risk of bias assessment, core outcome set, randomized controlled trials, primary and secondary outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis. https://app.cochat.ai/papers/10.1136/bmjopen-2013-002709
The paper
Dwan, K., Kirkham, J. J., Williamson, P. R., & Gamble, C. (2013). Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis. BMJ Open. https://doi.org/10.1136/bmjopen-2013-002709

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.